喘乐宁与爱喘乐联合辅舒酮吸入治疗毛细支气管炎128例临床分析  

Effect of atomize inhaling Salbutamol sulfate,Fluticasone propionate and Ipratropium bronude on the treatment of Bronchiolitis

作　　者：多力坤.木扎帕尔 马香萍[1] 王艳红[1] 

机构地区：[1]新疆医科大学第一附属医院儿科,新疆乌鲁木齐830011

出　　处：《新疆医科大学学报》2008年第7期851-852,共2页Journal of Xinjiang Medical University

摘　　要：目的:探讨喘乐宁与爱喘乐联合辅舒酮吸入治疗毛细支气管炎的临床疗效。方法:毛细支气管炎患儿128例,随机分为观察组(69例)与对照组(59例)。观察组在常规治疗基础上给予喘乐宁与爱喘乐联合辅舒酮吸入,观察2组治愈率及解除主要症状和体征的时间。结果:观察组治愈率、缓解喘憋症状及缩短哮鸣音持续时间均明显优于对照组(P<0.05)。结论:喘乐宁与爱喘乐联合辅舒酮吸入治疗毛细支气管炎显效迅速,疗效显著。Objective： To investigate the effect of atomize inhaling Salbutamol sulfate, Fluticasone propionate and Ipratropium bronude on the treatment of bronchiolitis. Methods： 128 patients with bronchiolitis were divided into observation group and control group. The observation group was atomizing inhaling Salbutamol sulfate, Fluticasone propionate and Ipratropium bronude. The control group was given routine treatment. Result： The effective rate of observation group was better than that of the control group. The difference between the two groups was significant （P 〈0.05）. Conclusion： The curative effect of atomize inhaling Salbutamol sulfate, Fluticasone propionate and Ipratropium bronude on the treatment of bronchiolitis was faster and better.

关 键 词：喘乐宁 爱喘乐 辅舒酮 毛细支气管炎 

分 类 号：R974[医药卫生—药品] R562.2[医药卫生—药学]